ClinicalTrials.govpublic full text
Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
atrial fibrillation, end-stage kidney disease, kidney disease, anticoagulation, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 966314
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.